View Older Stories View More Recent Stories

May 21, 2020 07:00AM Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD
May 11, 2020 04:15PM Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments
Apr 27, 2020 06:19AM Sutro Biopharma Inc. (STRO) Reports Encouraging Interim Ph. 1 Clinical Data for Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
Apr 27, 2020 12:01AM Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
Apr 20, 2020 04:35PM Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate
Apr 13, 2020 05:00PM Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020
Mar 16, 2020 07:00AM Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
Mar 12, 2020 07:00AM Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck
Mar 4, 2020 07:00AM Sutro Biopharma to Present Innovative Cancer Therapy Approach Using Precise Tumor Targeted Immunostimulants at World ADC London
Feb 27, 2020 07:00AM Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 5, 2020 07:30AM Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Jan 9, 2020 07:00AM Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference
Jan 8, 2020 09:26AM Sutro Biopharma Appoints James Panek to Board of Directors
Nov 26, 2019 07:00AM Sutro Biopharma to Participate in the 31st Annual Piper Jaffray Healthcare Conference
Nov 19, 2019 07:00AM Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference
Nov 8, 2019 07:00AM Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
Oct 29, 2019 07:28AM Sutro Biopharma Inc. (STRO) Highlights Encouraging Prelim. Clinical Data in Ongoing Ph. I Study for STRO-002 Antibody-Drug Conjugate in Patients w/ Advanced Ovarian Cancer
Oct 29, 2019 07:00AM Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer
Oct 16, 2019 04:35PM Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Oct 8, 2019 07:05AM Sutro Biopharma Inc. (STRO) to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Oct 8, 2019 07:00AM Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Sep 4, 2019 07:00AM Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
Aug 14, 2019 06:15AM Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
Aug 8, 2019 07:00AM Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jun 24, 2019 04:09PM Sutro Biopharma Inc. (STRO) Announces Connie Matsui as Board Chair
Jun 24, 2019 04:05PM Sutro Biopharma Appoints Biopharma Veteran Connie Matsui as Board Chair
Jun 18, 2019 07:00AM Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
Jun 17, 2019 05:45AM Sutro Biopharma Inc. (STRO) Reports Encouraging Interim Phase 1 Safety Data on STRO-001 for Treatment of B-cell Malignancies
Jun 15, 2019 06:00AM Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Ass
May 16, 2019 09:02AM Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
May 15, 2019 07:00AM Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments
Apr 4, 2019 07:00AM Sutro Biopharma to Present at the 18th Annual Needham Healthcare Conference
Apr 1, 2019 05:00AM Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments
Mar 15, 2019 07:00AM Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers
Mar 5, 2019 07:00AM Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
Jan 29, 2019 07:00AM Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry
Jan 3, 2019 04:05PM Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference
Dec 19, 2018 07:06AM Sutro Biopharma Inc. (STRO) Secures $10M Milestone Payment from Celgene (CELG)
Dec 19, 2018 07:00AM Sutro Achieves $10 Million Milestone Payment from Celgene
Nov 26, 2018 07:00AM Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference
Nov 14, 2018 05:33PM Sutro Biopharma Reports Third Quarter 2018 Financial Results
Nov 13, 2018 07:12AM Sutro Biopharma Inc. (STRO) Reports IND Submission & Conclusion of 30-Day Review Period for STRO-002 in Phase 1 Clinical Study Evaluation
Nov 13, 2018 07:00AM Sutro Announces IND Submission and Conclusion of 30-Day Review Period for STRO-002, an Antibody-Drug Conjugate (ADC) Targeting Anti-Folate Receptor-α for Treatment of Ovarian and Endometrial Cancer
Nov 8, 2018 07:00AM Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Oct 12, 2018 07:04AM Sutro Biopharma, Inc. (STRO) Granted FDA Orphan Drug Designation for STRO-001 for Treatment of Multiple Myeloma
Oct 12, 2018 07:00AM Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma
View More Recent Stories View Older Stories